this post was submitted on 07 Nov 2024
17 points (94.7% liked)

Health - Resources and discussion for everything health-related

2321 readers
277 users here now

Health: physical and mental, individual and public.

Discussions, issues, resources, news, everything.

See the pinned post for a long list of other communities dedicated to health or specific diagnoses. The list is continuously updated.

Nothing here shall be taken as medical or any other kind of professional advice.

Commercial advertising is considered spam and not allowed. If you're not sure, contact mods to ask beforehand.

Linked videos without original description context by OP to initiate healthy, constructive discussions will be removed.

Regular rules of lemmy.world apply. Be civil.

founded 1 year ago
MODERATORS
 

Summary

Novo Nordisk provided updates on its next-generation obesity and diabetes drug, CagriSema, a potential successor to Ozempic and Wegovy.

CagriSema combines semaglutide with an amylin and calcitonin receptor agonist, promising enhanced weight loss and blood sugar regulation.

Early trials showed 15.6% weight loss over 32 weeks, and executives are optimistic larger trials could show up to 25% weight loss.

Results from late-stage trials are expected by mid-2025.

top 4 comments
sorted by: hot top controversial new old
[–] DScratch@sh.itjust.works 7 points 1 week ago

And so, the cycle of minor, but copyrighted updates begins.

[–] scytale@lemm.ee 2 points 1 week ago (1 children)

Can someone more knowledgeable than me please ELI5 how this drug is so revolutionary and why it only came to be recently? Based on what I see on articles, it seems like the equivalent of a cure for cancer, but for obesity amd weight loss instead. Is it the result of years and years of research and testing, and/or a breakthrough discovery of the chemical that makes it work?

[–] mark3748@sh.itjust.works 6 points 1 week ago* (last edited 1 week ago)

It’s a happy accident. They were working on a diabetes treatment, which they did develop. The side effects included weight loss, so it started to get prescribed off-label for that. Then they did the required testing to get it approval for weight-loss.

It works because it is a fake hormone that mimics GLP-1, a hormone that is involved with appetite regulation. When it binds to the GLP-1 receptors it causes more insulin to be released in response to sugars which lowers blood sugars. The weight loss doesn’t come from that, though, it comes from the appetite suppression.

A lot of people seem to think you can eat as much as you want while you’re taking it. That’s technically true, but really because you won’t want to eat much.

[–] sunzu2@thebrainbin.org 1 points 1 week ago

Ohh yes daddy, give me that good shit